<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant CD2 expression in childhood precursor-<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B ALL</z:e> is rare and has recently been reported with an incidence of 3.6% in a study by Cantu-Rajnoldi et al </plain></SENT>
<SENT sid="1" pm="."><plain>[Haematologica 77:384, 1992] </plain></SENT>
<SENT sid="2" pm="."><plain>There was no association of the CD2 co-expression with other known prognostic factors </plain></SENT>
<SENT sid="3" pm="."><plain>Our study represents the second one in the literature </plain></SENT>
<SENT sid="4" pm="."><plain>Out of 60 childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo>, analyzed morphologically and by flow cytometric immunophenotyping, 49 were of precursor B origin </plain></SENT>
<SENT sid="5" pm="."><plain>Of these 49 cases, CD2 co-expression was detected in 2, yielding an incidence of 4.1% </plain></SENT>
<SENT sid="6" pm="."><plain>The complete immunophenotypic profiles of these two cases were as follows, respectively: (1) CD19+, CD20-, CD24+, CD10+, sig-, CD2+, CD3-, CD5-, CD7-, CD13-, CD33-, CD34+, Tdt+; and (2) CD19+, CD20-, CD24+, CD10+, sig-, CD2+, CD3-, CD5-, CD7-, CD13+, CD33-, CD34+, Tdt+ </plain></SENT>
<SENT sid="7" pm="."><plain>Cytogenetic analysis revealed a <z:mpath ids='MPATH_458'>normal</z:mpath> male chromosome pattern in case 1 and an abnormal female chromosome pattern [4 cells: 46, XX, del (6q) (q21 q23) and 9 cells: 46, XX, del (11q) (q14 q23)] in case 2 </plain></SENT>
<SENT sid="8" pm="."><plain>Both patients were in continuous complete remission at last follow-up </plain></SENT>
</text></document>